• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6279例N1期分化型甲状腺癌患者的淋巴结特征

Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients.

作者信息

Sui C, He Q, Du R, Zhang D, Li F, Dionigi G, Liang N, Sun H

机构信息

Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun City, China.

Division for Endocrine and Minimally Invasive Surgery, Department of Human Pathology in Adulthood and Childhood 'G. Barresi', University Hospital 'G. Martino', The University of Messina, Messina, Italy.

出版信息

Endocr Connect. 2020 Mar;9(3):201-210. doi: 10.1530/EC-20-0019.

DOI:10.1530/EC-20-0019
PMID:31961797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7040862/
Abstract

PURPOSE

This study examined the clinicopathological characteristics of 6279 N1 differentiated thyroid cancer (DTC) patients who underwent operations in our center.

METHODS

This was a retrospective longitudinal analysis. We categorized the DTC patients on the basis of various lymph node (LN) characteristics. Logistic regression models and multiple linear regression models were used for the correlation analysis.

RESULTS

A total of 3693 (58.8%) N1a patients and 2586 (41.2%) N1b patients were included. Patients with N1b disease had larger metastatic foci (0.5 vs 0.15 cm), a greater number of metastatic LNs (5 vs 2), a greater number of dissected LNs (25 vs 7), and a smaller lymph node ratio (NR, number of positive LNs/number of sampled LNs) (23.1% vs 28.6%) than patients in stage N1a. Comparing the clinicopathological features, we found that male, increased tumor size, multifocality, and thyroiditis increased the risk of stage N1b disease (P < 0.05). Sex, multifocality, capsular infiltration, and tumor size were associated with the size of the metastatic LNs (P < 0.05). Sex, capsular infiltration, and nodular goiter were associated with the NR (P < 0.05). Female sex, tumor located in inferior lobe, maximal tumor diameter (MTD) < 1 cm, and nodular goiter were independent predictors for skip metastases (P < 0.05). MTD > 1 cm, central neck metastasis and age were independent predictors for bilateral lateral neck metastasis (BLNM) (P < 0.05).

CONCLUSION

The LN characteristics of stage N1a and N1b disease were associated with significantly different features, such as sex, tumor size, multifocality, capsular infiltration, and nodular goiter.

摘要

目的

本研究探讨了在我院中心接受手术的6279例N1期分化型甲状腺癌(DTC)患者的临床病理特征。

方法

这是一项回顾性纵向分析。我们根据各种淋巴结(LN)特征对DTC患者进行分类。采用逻辑回归模型和多元线性回归模型进行相关性分析。

结果

共纳入3693例(58.8%)N1a期患者和2586例(41.2%)N1b期患者。与N1a期患者相比,N1b期患者的转移灶更大(0.5 vs 0.15 cm)、转移淋巴结数量更多(5 vs 2)、清扫淋巴结数量更多(25 vs 7)、淋巴结转移率(NR,阳性淋巴结数量/采样淋巴结数量)更低(23.1% vs 28.6%)。比较临床病理特征,我们发现男性、肿瘤大小增加、多灶性和甲状腺炎会增加N1b期疾病的风险(P < 0.05)。性别、多灶性、包膜浸润和肿瘤大小与转移淋巴结的大小相关(P < 0.05)。性别、包膜浸润和结节性甲状腺肿与NR相关(P < 0.05)。女性、肿瘤位于下叶、最大肿瘤直径(MTD)< 1 cm和结节性甲状腺肿是跳跃转移的独立预测因素(P < 0.05)。MTD > 1 cm、中央区颈部转移和年龄是双侧侧颈部转移(BLNM)的独立预测因素(P < 0.05)。

结论

N1a期和N1b期疾病的LN特征与显著不同的特征相关,如性别、肿瘤大小、多灶性、包膜浸润和结节性甲状腺肿。

相似文献

1
Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients.6279例N1期分化型甲状腺癌患者的淋巴结特征
Endocr Connect. 2020 Mar;9(3):201-210. doi: 10.1530/EC-20-0019.
2
Effect of skip metastasis to lateral neck lymph nodes on outcome of patients with papillary thyroid carcinoma.颈侧区跳跃转移对甲状腺乳头状癌患者预后的影响。
Langenbecks Arch Surg. 2022 Nov;407(7):3025-3030. doi: 10.1007/s00423-022-02604-7. Epub 2022 Jul 12.
3
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.颈侧区淋巴结转移(N1b)是甲状腺乳头状癌预后的另一个危险因素。
J Endocrinol Invest. 2017 Dec;40(12):1355-1363. doi: 10.1007/s40618-017-0714-y. Epub 2017 Jun 23.
4
Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.颈侧区淋巴结转移的儿童甲状腺癌中预测复发风险的淋巴结比值和转移淋巴结大小的最佳值。
J Pediatr Surg. 2023 Mar;58(3):568-573. doi: 10.1016/j.jpedsurg.2022.07.010. Epub 2022 Jul 13.
5
Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years.波兰儿童分化型甲状腺癌临床特征变迁:一项跨越 45 年的回顾性队列研究。
Thyroid. 2024 Oct;34(10):1234-1245. doi: 10.1089/thy.2024.0109. Epub 2024 Sep 25.
6
Cystic Lateral Lymph Node Metastases From Papillary Thyroid Cancer Patients.甲状腺乳头状癌患者的囊性侧方淋巴结转移
Laryngoscope. 2020 Dec;130(12):E976-E981. doi: 10.1002/lary.28631. Epub 2020 Apr 10.
7
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.病理 N1a 期甲状腺乳头状癌中转移淋巴结比率和最大转移肿瘤大小的预后价值。
Eur J Endocrinol. 2013 Jan 17;168(2):219-25. doi: 10.1530/EJE-12-0744. Print 2013 Feb.
8
Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.N1b 期甲状腺乳头状癌患者发生 V 区转移的危险因素。
World J Surg Oncol. 2022 Sep 30;20(1):327. doi: 10.1186/s12957-022-02782-0.
9
Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma.甲状腺微小乳头状癌患者侧方淋巴结转移及跳跃转移的预测因素
Front Endocrinol (Lausanne). 2024 Jul 2;15:1392247. doi: 10.3389/fendo.2024.1392247. eCollection 2024.
10
Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients.分化型甲状腺癌:ATA 颈部淋巴结危险因素在 N1b 患者中的作用。
Laryngoscope. 2021 Mar;131(3):E1029-E1034. doi: 10.1002/lary.29057. Epub 2020 Sep 10.

引用本文的文献

1
The relationship between lateral cervical lymph node positivity rate and recurrence after comprehensive treatment in differentiated thyroid carcinoma: a single-center retrospective cohort study from China.分化型甲状腺癌综合治疗后颈部侧方淋巴结阳性率与复发的关系:一项来自中国的单中心回顾性队列研究
Front Oncol. 2025 Feb 13;15:1484002. doi: 10.3389/fonc.2025.1484002. eCollection 2025.
2
Evaluating the efficacy of the endoscopic thyroidectomy via sternocleidomastoid muscle posteroinferior approach in identifying occult lateral cervical lymph node metastasis.评估经胸锁乳突肌后下入路内镜甲状腺切除术在识别隐匿性侧颈淋巴结转移中的疗效。
Gland Surg. 2024 Nov 30;13(11):1986-1995. doi: 10.21037/gs-24-340. Epub 2024 Nov 26.
3

本文引用的文献

1
Sentinel Lymph Node Biopsy in Thyroid Cancer.甲状腺癌前哨淋巴结活检。
World J Surg. 2020 Jan;44(1):142-147. doi: 10.1007/s00268-019-05218-1.
2
Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe.位于一侧叶的乳头状甲状腺癌同侧和对侧颈部区域的侧方转移
ANZ J Surg. 2019 Nov;89(11):E498-E501. doi: 10.1111/ans.15458. Epub 2019 Sep 30.
3
Predictive Factors of Skip Metastasis in Papillary Thyroid Cancer.甲状腺乳头状癌跳跃性转移的预测因素。
PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.
位于上极的甲状腺乳头状癌更容易发生侧方淋巴结转移和跳跃转移。
World J Surg Oncol. 2020 Jul 28;18(1):188. doi: 10.1186/s12957-020-01965-x.
Med Sci Monit. 2018 May 3;24:2744-2749. doi: 10.12659/MSM.907357.
4
Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.第八版甲状腺癌肿瘤-淋巴结-转移分期系统中 N1b 分类的预后意义。
Thyroid. 2018 Apr;28(4):496-503. doi: 10.1089/thy.2017.0473. Epub 2018 Apr 5.
5
Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.第八版 AJCC TNM 分类和伴有侧方淋巴结转移的甲状腺乳头状癌预后分组的修订。
Oral Oncol. 2018 Mar;78:80-86. doi: 10.1016/j.oraloncology.2018.01.021. Epub 2018 Feb 20.
6
Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study.韩国分化型甲状腺癌患者的疾病特异性死亡率:一项多中心队列研究。
Endocrinol Metab (Seoul). 2017 Dec;32(4):434-441. doi: 10.3803/EnM.2017.32.4.434. Epub 2017 Nov 22.
7
Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.甲状腺乳头状癌的隐匿性转移在临床实践中难以预测。
BMC Cancer. 2017 Oct 25;17(1):702. doi: 10.1186/s12885-017-3698-2.
8
The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery.STROCSS 声明:加强外科学队列研究报告。
Int J Surg. 2017 Oct;46:198-202. doi: 10.1016/j.ijsu.2017.08.586. Epub 2017 Sep 7.
9
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.第八版 AJCC 癌症分期手册:继续从基于人群的方法向更“个体化”的癌症分期方法构建桥梁。
CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17.
10
[An introduction of surgical update in 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer].[2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌患者管理指南中的手术进展介绍]
Zhonghua Wai Ke Za Zhi. 2016 Mar 1;54(3):172-6. doi: 10.3760/cma.j.issn.0529-5815.2016.03.004.